FRIDAY, March 25, 2022 (HealthDay News) — The COVID-related death rate among Americans who received Johnson & Johnson’s COVID-19 vaccine was more than double that of people who received other vaccines, new data from the Omicron surge show. For the week of Jan. 8, as cases of the highly contagiousContinue Reading
FRIDAY, March 25, 2022 (HealthDay News) — Psilocybin, the psychedelic substance in “magic” mushrooms, is generating lots of interest as a potential treatment for a host of mental ills, but new research warns there is little data on how it might interact with more traditional psychiatric medications. “There’s a majorContinue Reading
THURSDAY, March 24, 2022 (HealthDay News) — Something as simple as aspirin may help lower the risk of death in hospital patients who are fighting a tough case of COVID-19, a new study found. George Washington University researchers analyzed data on more than 112,000 patients hospitalized with moderate COVID-19 atContinue Reading
THURSDAY, March 24, 2022 (HealthDay News) — The new Omicron subvariant, BA.2, is spreading across the United States and will soon take over as the major COVID variant, White House chief medical adviser Dr. Anthony Fauci said Tuesday. “Ultimately it will be the predominant variant in this country,” Fauci toldContinue Reading
THURSDAY, March 24, 2022 (HealthDay News) — Millions of people taking statin drugs to lower their cholesterol may get an unanticipated benefit: They may be less likely to develop movement and balance problems like those seen in Parkinson’s disease, a new study suggests. The study looked at the relationship betweenContinue Reading
THURSDAY, March 24, 2022 (HealthDay News) — Even though medication is considered the most effective therapy for opioid addiction, many Americans who need it don’t receive it, a new study finds. “Evidence supporting the effectiveness of medication for opioid use disorder — such as methadone, buprenorphine or naltrexone — isContinue Reading
THURSDAY, March 24, 2022 (HealthDay News) — A lower dose of a widely used COVID-19 drug is just as effective as a higher dose, new research shows. Tocilizumab (Actemra) is a rheumatoid arthritis drug that has become the standard of care for treating severe COVID-19, but high demand and productionContinue Reading
WEDNESDAY, March 23, 2022 (HealthDay News) — Moderna announced Wednesday that it will ask the U.S. Food and Drug Administration to approve the emergency use of its COVID-19 vaccine for children under 6. The company said that its request is based on interim results from its clinical trial that showed,Continue Reading
WEDNESDAY, March 23, 2022 (HealthDay News) — In a finding that could influence future COVID vaccine recommendations for the youngest Americans, new research finds that infants and toddlers have a stronger immune response to the new coronavirus than adults do. To arrive at that conclusion, scientists analyzed blood samples collectedContinue Reading
TUESDAY, March 22, 2022 (HealthDay News) — Medical marijuana could be a viable alternative to opioid painkillers for people dealing with arthritis or chronic back pain, two new studies show. Many patients prescribed opioids for their chronic pain wound up taking fewer painkillers — or stopping them altogether — afterContinue Reading